undamentalytics Newsletter
Sign in

Owlet, Inc. revenue

Owlet, Inc.'s revenue was $106m in fiscal 2025, up 37.1% on the year before. Since fiscal 2020 ($75.4m) it has grown at a compound 7.1% a year. Over the last twelve months it was $115m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue7576695477106115
Growth on the year before—+0.6%−8.8%−22.0%+43.3%+37.1%—
Gross profit36352323395463

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
United States $86.5M 81.8% ▲ 37.5%
Outside the US $13.3M 12.6% ▲ 33.6%
United Kingdom $5.9M 5.6% ▲ 14.1%

From Owlet, Inc.'s 10-K filed March 9, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Owlet, Inc. $115m 28.2% 29.3%
Outset Medical, Inc. $118m -1.3% -3.1%
Sanara Medtech Inc. $110m 13.0% 22.6%
Xtant Medical Holdings, Inc. $110m -14.3% 17.3%
Anika Therapeutics, Inc. $121m 5.3% 0.3%
Beta Bionics, Inc. $127m 43.7% —

Compare with peers

Head to head: OM vs OWLTOWLT vs SMTIOWLT vs XTNTANIK vs OWLT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Owlet, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Owlet, Inc.